Sign in
Explore the registryTrack Tarlatamab's trials

START-lung

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

TarlatamabOngoingRecruitingPhase 2Open NCT07203053 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…